From the Literature

Published: Sep 2015

Ferraris VA, Hochstetler M, Martin JT, Mahan A, Saha SP

Blood transfusion and adverse surgical outcomes: The good and the bad.
Surgery 2015;158:608-617.

#

NATA REVIEW:
In this article, Ferraris and coworkers attempt to identify patient characteristics that can differentiate patients...
REVIEW by:
O. Habler

Published: Sep 2015

McKinney ZJ, Peters JM, Gorlin JB, Perry EH

Improving red blood cell orders, utilization, and management with point-of-care clinical decision support.
Transfusion 2015;55:2086-2094.

#

NATA REVIEW:
Praise for a method that implements the single-unit order! Almost all over the world, the old doctrine...
REVIEW by:
T. Frietsch

Published: Aug 2015

Douketis JD, Spyropoulos AC, Kaatz S, et al.

Perioperative bridging anticoagulation in patients with atrial fibrillation.
N Engl J Med 2015;373:823-833.

#

NATA REVIEW:
Perioperative management of anticoagulation is sometimes complex and challenging. Different factors influencing...
REVIEW by:
D. Faraoni

Published: Aug 2015

Pollack CV, Jr., Reilly PA, Eikelboom J, et al.

Idarucizumab for dabigatran reversal.
N Engl J Med 2015;373:511-520.

#

NATA REVIEW:
Dabigatran etexilate, a direct thrombin inhibitor, has been increasingly used over the last few years, but the...
REVIEW by:
D. Faraoni

Published: Aug 2015

Glund S, Stangier J, Schmohl M, et al.

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Lancet 2015;386:680-690.

#

NATA REVIEW:
Dabigatran etexilate is a direct thrombin inhibitor increasingly used for stroke prevention in patients with...
REVIEW by:
D. Faraoni

Published: Aug 2015

Butler CE, Noel S, Hibbs SP, et al.

Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients.
Transfusion 2015;55:1964-1971.

#

NATA REVIEW:
The authors report the impact of a clinical decision support system at a single centre to improve transfusion...
REVIEW by:
L. T. Goodnough

Published: Aug 2015

Caldeira D, Rodrigues FB, Barra M, et al.

Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
Heart 2015;101:1204-1211.

#

NATA REVIEW:
Non-vitamin K antagonist oral anticoagulants (NOACs) are alternatives to vitamin K antagonists (VKAs) for the...
REVIEW by:
F. Bonhomme

Published: Jul 2015

Clark NP, Witt DM, Davies LE, et al.

Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures.
JAMA Intern Med 2015;175:1163-1168.

#

NATA REVIEW:
Preoperative management of patients treated with vitamin K antagonists who require elective surgical procedures...
REVIEW by:
D. Faraoni

Published: Jul 2015

Muñoz M, Gomez-Ramirez S, Kozek-Langeneker S, et al.

'Fit to fly': overcoming barriers to preoperative haemoglobin optimization in surgical patients.
Br J Anaesth 2015;115:15-24.

#

NATA REVIEW:
This is a most interesting review on patient blood management (PBM) authored by experts in the field. The...
REVIEW by:
J.-F. Hardy

Published: Jul 2015

Curry N, Rourke C, Davenport R, et al.

Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial.
Br J Anaesth 2015;115:76-83.

#

NATA REVIEW:
In this unblinded randomised controlled trial that enrolled 43 adult trauma patients at two major UK civilian...
REVIEW by:
S. R. Ostrowski

Pages